Seluang Fish (Rasbora Spp.) Oil Decreases Inflammatory Cytokines Via Increasing Vitamin D Level in Systemic Lupus Erythematosus
BACKGROUND: Systemic Lupus Erythematosus (SLE) is an autoimmune disorder mediated by inflammatory cytokines. Decreasing vitamin D levels is a common feature in SLE patients. Vitamin D has the capacity in suppressing inflammatory cascade. Seluang fish (Rasbora spp.) contained a high level of vitamin D with the potential as a new therapeutic modality.
AIM: This study aimed to assess the efficacy of Seluang fish oil against proinflammatory cytokines, vitamin D levels, and clinical conditions of SLE.
METHODS: A randomised, double-blind, clinical trial study design was conducted. The subjects were 16 SLE subjects treated with 500uL Seluang fish oil capsules and 16 SLE subjects with placebo capsules. Measurement of vitamin D, IL-1, IL-6 and IL-17 levels were performed with ELISA. Clinical assessment of SLE was performed with MEX-SLEDAI. Bivariate analysis, T-test, was performed. Data were presented in the form of mean Â± SD.
RESULTS: The administration of Seluang fish oil was clinically able to show efficacy assessed by the MEX SLEDAI score. Significant results were also shown by increased vitamin D levels and reduced levels of IL-1, IL-6 and IL-17, in Seluang fish oil group.
CONCLUSION: Seluang fish oil possessed the efficacy of reducing the inflammatory response in SLE patients by increasing serum vitamin D levels.
Plum Analytics Artifact Widget Block
Ministry Of the Health Republic Of Indonesia. Lupus. Ministry of the Health Republic of Indonesia. Jakarta, 2017.
Finzel S, Schaffer S, Rizzi M, Voll RE. Pathogenesis of systemic lupus erythematosus. Z Rheumatol. 2018; 77(9):789-98. https://doi.org/10.1007/s00393-018-0541-3 PMid:30291433
Ohl K, Tenbrock K. Inflammatory Cytokines in Systemic Lupus Erythematosus. J Biomed Biotechnol. 2011; 2011:1-14. https://doi.org/10.1155/2011/432595 PMid:22028588 PMCid:PMC3196871
Bishak YK, Ghavamzadeh S, Shokri A, Payahoo L, Khalili L, Hassanalilou T. Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation. Autoimmune Highlights. 2017; 9(1):1-10. https://doi.org/10.1007/s13317-017-0101-x
Handono K, Tanuwijaya LK, Fitri LE, Kalim H. The Correlation between Serum Concentration of Vitamin D with Vitamin D Receptor Expression and Disease Activity in Indonesian Patients with Systemic Lupus Erythematosus: Preliminary Study. J Trop Life Sci. 2016; 4(2):113-8. https://doi.org/10.11594/jtls.04.02.06
Partan RU, Hidayat R. The Potential Role of Seluang Fish Oil (Rasbora spp.) in Improving Calcium, Zinc and Vitamin D3 Deficiencies. IJOO. 2017; 11(2):285-91.
Condur L, Chirila S. The relationship between vitamin D and cardiovascular risk. Medic.ro. 2018; 2(1):8-12. https://doi.org/10.26416/MED.122.2.2018.1657
Dankers W, Colin EM, Van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: Molecular mechanisms and therapeutic potential. Front Immunol. 2017; 7:697. https://doi.org/10.3389/fimmu.2016.00697 PMid:28163705 PMCid:PMC5247472
Cannell JJ, Grant WB, Holick MF. Vitamin D and inflammation. Dermatoendocrinol. 2015; 6(1):e983401. https://doi.org/10.4161/19381980.2014.983401
Reihani H, Rastin M, Sahebari M, Mahmoudi M, Ghoryani M, Abdollahi N, Tabasi NS, Rabe SZT, Arab FL, Faraji F. Effects of Vit D on Th17 cells and related cytokines in lupus erythematosus patients. Front Immunol Conference Abstract: 15th International Congress of Immunology (ICI), 2013.
Salem ML, El-Badawy A. Programmed death-1 / programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy. World J Hepatol. 2015; 7(23):2449-58. https://doi.org/10.4254/wjh.v7.i23.2449 PMid:26483866 PMCid:PMC4606200
Sabry A, Elbasyouni SR, Sheashaa HA, Alhusseini AA, Mahmoud K, George SK, Kaleek EA, Abo-Zena H, Kalil AM, Mohsen T, Rahim MA, El-Samanody AZ. Correlation between levels of TNF-Î± and IL-6 and hematological involvement in SLE Egyptian Patients with lupus nephritis. Int Urol Nephrol. 2007; 38(3-4):731-7. https://doi.org/10.1007/s11255-006-0047-9
Umare V, Pradhan V, Nadkar M, Rajadhyaksha A, Patwardhan M, Ghosh KK, Nadkarni AH. Effect of proinflammatory cytokines (IL-6, TNF, and IL-1Î²) on clinical manifestations in indian SLE patients. Mediators Inflamm. 2014; 2014:1-8. https://doi.org/10.1155/2014/385297 PMid:25548434 PMCid:PMC4273527
Tahernia L, Namazi S, Rezaei N, Ziaee V. Cytokines in systemic lupus erythematosus: their role in pathogenesis of disease and possible therapeutic opportunities. Rheumatol Res. 2017; 2(1):1-9. https://doi.org/10.22631/rr.2017.69997.1010
Raymond W, Eilertsen GO, Griffiths S, Nossent J. IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role. Eur J Rheumatol. 2017; 4(1):29-35. https://doi.org/10.5152/eurjrheum.2017.16059 PMid:28293450 PMCid:PMC5335884
Saber NZ, Maroof SH, Soliman DA, Fathi MS. Expression of T helper 17 cells and interleukin 17 in lupus nephritis patients. Egypt Rheumatol. 2017; 39(3):151-7. https://doi.org/10.1016/j.ejr.2017.01.005
Copyright (c) 2019 Radiyati Umi Partan, Rachmat Hidayat, Nurwan Saputra, Febry Rahmayani, Hari Prapto, Timotius Wira Yudha
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All rights reserved.